$IMVT Income Statement | Understand Stock

Login

Ask AI

$IMVT

$28.17 -$0.24 (0.84%) Close

$IMVT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Operating expenses:
Research and development (includes $14,308 and $7,033 of stock-based compensation expense for the years ended March 31, 2022 and 2021, respectively)
Research and development
Acquired in-process research and development
General and administrative
Total operating expenses

Interest income, net
Other (income) expense, net
Loss before provision for income taxes
Provision for income taxes
Net loss
Net loss per common share — basic (in dollars per share)
Net loss per common share — diluted (in dollars per share)
Weighted average common shares outstanding — basic (in shares)
Weighted average common shares outstanding — diluted (in shares)

Loading...

Comments